Table 5.
BRAFV600E (n=295) | BRAFV600K (n=33) | |
---|---|---|
Total patients with ≥1 adverse event | 294 (100%) | 33 (100%) |
Arthralgia | 171 (58%) | 13 (39%) |
Rash | 123 (42%) | 13 (39%) |
Fatigue | 133 (45%) | 18 (55%) |
Photosensitivity | 120 (41%) | 12 (36%) |
Cutaneous squamous-cell carcinoma | 57 (19%) | 8 (24%) |
Keratoacanthoma | 29 (10%) | 7 (21%) |
Skin papilloma | 85 (29%) | 9 (27%) |
Nausea | 117 (40%) | 8 (24%) |
Data are number of patients (%).